Solara Active Pharma Sciences Limited — Results, 29-01-2025: Integrated Filing- Financial

Solara Active Pharma Sciences Limited has submitted its consolidated financial results for the quarter and nine months ending December 31, 2024. The company reported a revenue of ₹1,567.3 crore, with net losses accumulating to approximately ₹310.7 crore. To address its financial challenges, Solara raised ₹157.48 crore through a rights issue but continues to face liquidity issues, with current liabilities exceeding current assets by ₹266.06 crore. The Board has explored a potential demerger of its CRAMS and Polymers businesses, signaling a strategic shift that may attract investor interest by addressing operational focus. Investor sentiment may remain cautious, balancing the need for operational improvement against ongoing financial strains.